Evidence map›Paper›PMID 41131361›Full record

ArticleNature neuroscience2025

A glial circadian gene expression atlas reveals cell-type and disease-specific reprogramming in response to amyloid pathology or aging.

Patrick W Sheehan, Stuart B Fass, Darshan Sapkota, Sylvia Kang, Henry C Hollis, Jennifer H Lawrence, Sohui Park, Ashish Sharma, Dorothy P Schafer, Ron C Anafi and 3 more

Abstract read
In one paragraph

Article in Nature neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. bioRxiv : the preprint server for biology · 2026
    Article
  10. NADAlzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Patrick W SheehanDepartment of Neurology, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0001-8476-6246
Stuart B FassDepartment of Genetics, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0002-5071-2407
Darshan SapkotaDepartment of Genetics, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0003-3773-2910
Sylvia KangDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Henry C HollisSchool of Biomedical Engineering and Health Systems, Drexel University, Philadelphia, PA, USA.
Jennifer H LawrenceDepartment of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
Sohui ParkDepartment of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
Ashish SharmaDepartment of Neurology, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0001-9998-9709
Dorothy P SchaferDepartment of Neurobiology, Brudnick Neuropsychiatric Research Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Ron C AnafiDepartment of Medicine, Chronobiology and Sleep Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Joseph D DoughertyDepartment of Genetics, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0002-6385-3997
John D FryerBioinnovation and Genome Sciences Division & Center for Accelerated Nanotherapeutics, Translational Genomics Research Institute, Phoenix, AZ, USA.ORCID http://orcid.org/0000-0003-3390-2994
Erik S MusiekDepartment of Neurology, Washington University School of Medicine, St. Louis, MO, USA. musieke@wustl.edu.ORCID http://orcid.org/0000-0002-8873-0360

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Microglia-dependent mechanisms governing neural circuit plasticityR01MH113743 · NIMH · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Dorothy Patricia Schafer · 2017 to 2026
$4.9M
ROLE OF GLIAL CIRCADIAN CLOCK DYSFUNCTION IN THE PATHOGENESIS OF ALZHEIMER'S DISEASER01AG054517 · NIA · WASHINGTON UNIVERSITY · PI Erik Steven Musiek · 2017 to 2026
$4.5M
Regulation of local translation in gliaR01NS102272 · NINDS · WASHINGTON UNIVERSITY · PI JOSEPH D DOUGHERTY · 2017 to 2026
$3.8M
Multidisciplinary Training in Alzheimer and Related DementiasT32AG058518 · NIA · WASHINGTON UNIVERSITY · PI Eric Martin McDade, Barbara Joy Snider · 2018 to 2026
$2.3M
How Do Synaptic Connections Change in Demyelinating Disease?R01NS117533 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SCHAFER, DOROTHY PATRICIA · 2021 to 2025
$2.2M
Circadian Organization and Disorder in Alzheimer's DiseaseR01AG068577 · NIA · UNIVERSITY OF PENNSYLVANIA · PI ANAFI, RON C. · 2020 to 2024
$2.0M
Neurobiological significance of Aqp4 stop codon readthroughR00AG061231 · NIA · UNIVERSITY OF TEXAS DALLAS · PI SAPKOTA, DARSHAN · 2021 to 2023
$722k
Dissecting the impact of senescence on microglia function and neurodegenerationR01AG068281 · NIA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SCHAFER, DOROTHY PATRICIA, ZHANG, HONG · 2024 to 2024
$419k
NCI NIH HHS P30 CA091842NIA NIH HHS R00 AG061231NIA NIH HHS R01 AG054517NIA NIH HHS R01 AG068281NIA NIH HHS R01 AG068577NIA NIH HHS T32 AG058518NIMH NIH HHS R01 MH113743NINDS NIH HHS R01 NS102272NINDS NIH HHS R01 NS117533U.S. Department of Health & Human Services | National Institutes of Health (NIH) R00AG061231U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01AG054517U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01AG068577U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01NS102272U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) R01AG054517U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) T32AG058518
6 · The paper itself

Abstract

While circadian rhythm disruption may promote neurodegenerative disease, the impact of aging and neurodegenerative pathology on circadian gene expression patterns in different brain cell types remains unknown. Here we used a translating ribosome affinity purification to identify the circadian translatomes of astrocytes, microglia and bulk tissue in healthy mouse cortex and in the settings of amyloid-β plaque pathology or aging. We show that glial circadian translatomes are highly cell-type-specific and exhibit profound, context-dependent reprogramming in response to amyloid pathology or aging. Transcripts involved in glial reactivity, immunometabolism and proteostasis, as well as nearly half of all Alzheimer's disease risk genes, displayed circadian oscillations, many of which were altered by pathology. Microglial oxidative stress and amyloid phagocytosis showed temporal variation in gene expression and function. Thus, circadian rhythms in gene expression are cell-dependent and context dependent, and provide important insights into glial function in health, Alzheimer's disease and aging.

Indexed as

AgingAlzheimer DiseaseCircadian RhythmNeurogliaPlaque, AmyloidAmyloid beta-PeptidesAnimalsAstrocytesMaleMiceMice, Inbred C57BLMicrogliaAmyloid beta-Peptides

Identifiers

PMID41131361
PMCPMC12586161

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.